Navigation Links
A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer

A recent study has shown that a chemotherapy regimen combining vinorelbine (Navelbine) and mitoxantrone (Novantrone)// with the corticosteroid prednisone is effective in the treatment of hormone-refractory prostate cancer . Specialists say this treatment should be offered to symptomatic patients earlier in their disease.

However researchers added that a larger phase 2 study of this treatment regimen is planned. From a group of 66 patients who had advanced prostate cancer, the investigators recruited 12 for whom previous hormone therapy had failed in at least 3 lines of treatment.

The investigators included patients who had undergone palliative radiotherapy at any point during their disease. The patient’s median age was 67 years, with a range of 60 to 81 years. The patient’s median Eastern Cooperative Oncology Group performance status was 1, with a range of 0 to 2. All the patients had bone metastases, some with multiple sites. One patient had lymph node metastasis, and 1 had visceral disease. Three patients had significant ischaemic heart disease.

Each treatment cycle consisted of 10 to 12 mg/m2 of mitoxantrone on day 1, followed by 20 mg/m2 of vinorelbine on days 1 through 8. This cycle was repeated every 3 weeks. The patients also received 12.5 mg daily of prednisone. A total of 95 cycles were given, with a median of 7 cycles per patient and a range of 5 to 9 cycles per patient. Two patients repeated the treatment at 6 months and 12 months after the initial treatment. Among these patients, 50% had a marked decrease in pain and improvement in ECOG performance status, according to specialists. In 8 cycles, due to the response to treatment, the dose of vinorelbine was reduced 50% and in 4 cycles it was reduced 75%. The mitoxantrone dose was reduced 50% in 5 cycles. Although 1 patient had a drop in prostate specific antigen (PSA) of more than 50%, the computed tomography findings did not show an equivalent response.

The patients'
'"/>




Page: 1 2

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. Combination Therapy Effective In Improving Lung Cancer Survival
8. Combination Therapy Found To Improves Stroke Recovery
9. Combination Therapy Found To Be More Effective In Treating Brain Cancer
10. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
11. New Combination Therapy Option for HIV Patients
Post Your Comments:
(Date:12/2/2008)... Randomized Comparator Study to Evaluate Efficacy... , , WOODCLIFF LAKE, N.J., Dec. 2 /PRNewswi...nounced that it plans to initiate the first clinic...citabine for injection) compared to Vidaza(R) (aza...ntermediate-2 or high-risk myelodysplastic syndrom...
(Date:12/2/2008)... DENVER, Dec. 2 Barotz Dental is ...fering LANAP(TM) (Laser Assisted New Attachment,P...rotocol that is patented,and FDA approved for new..., LANAP removes diseased tissue, without rem... tissue around teeth, minimizes pain and discomfor...
(Date:12/2/2008)... DENVER, Dec. 2 Global ...ompany") (OTC Bulletin Board: GLOB), an internatio...any, today announced that its,European subsidiary...on,Software, marketed as "Hemo Serveur" in France..."AP-HP") hospitals, representing 23,000 patient be...
(Date:12/2/2008)... FISHERS, Ind., Dec. 2 A number o... rise in childhood obesity, the health risks in,o...al value of cereals and,other foods kids consume....,-- offers all natural, freeze-dried real fruit pr...ids, but also provide most, if not all, of the dai...
Breaking Medicine News(10 mins):Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3Health News:Barotz Dental Now Offering Laser Gum Therapy 2Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 2Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 3Health News:Global Med Technologies(R)' European Subsidiary to Provide Strategic Blood Transfusion Software for 21 Paris Hospitals 4Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3
... heart becomes so enlarged that it is no longer ab...s 35 in every 100,000 people. Researchers in the U...ished in the journal Science that a defect in the ...ays a key role in regulating the flow of calcium t...
...f The Anatomical Record has put together a collect...ry repair in animals. Spinal cord injury affects m...th little hope of living a normal life. However, r...tem cells - primitive cells that can turn into spe...
...ases in our society with more than five million pe...one. According to a major study in the UK, in whic...st 900,000 asthma patients across the UK, asthma s...t being prescribed the most suitable inhalers. The...
...at can often be fatal. Methadone has been one of t... However, the major concern in treating heroin add...ddictive. This is one reason methadone therapy is ...tudy has now found that an alternative drug therap...
Other Medicine News:
(Date:11/26/2008)...e-USNewswire/ -- Children whose eyes are misaligne... risk of developing mental illness by early adulth... published this month in Pediatrics , the official... , The retrospective study examined the medi...igned eyes) and compared them with records of chil...
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-FirstCa...) announced today that it has received full approv...) for its U.S. pivotal trial to study the effectiv...associated therapy in the prevention of Contrast-I...approved PLC,s request to expand their investigati...
(Date:11/25/2008)...-USNewswire/ -- Kleinert Kutz and University of L...hand transplant on Messina, New York resident, Jan...Hand Care Center on Monday, November 24. The inno...ed shortly after 9 p.m. in a record nine hours. ,...prnh/20081125/DC48555-a ) , (Photo: http://ww...
(Date:11/25/2008)... Proteolix, Inc., a,leader in the...hat target,protein degradation pathways in cancer...ta from two ongoing Phase 2 clinical trials of car... the upcoming 50th Annual Meeting of the,American...first in a new class,of specific proteasome inhib...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 1BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 2BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 4Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 1Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 2Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 3Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 4Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 1Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 1WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 3
... SEATTLE, June 04, 2007 /PRNewswire-FirstCall/ --...indings were presented from a,Phase 1b clinical tr...eukemia (B-CLL) at the American Society of Clinica...ncluded intravenous,administration of higher doses...ound that atacicept was well-tolerated and biologi...
... HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jun 4, 2007 - A...nnounced that the,Company presented a "meta-analys... Fampridine-SR in multiple sclerosis during a,post... and Research,in MS (ACTRIMS) Meeting in Washingto...lidation of Consistent Improvement in Walking,Spee...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: